All In MedTech

Device Trial Radar · NCT05304650

A Usability Study of External Neuromodulation With iTEAR100 Generation 2

Last checked: Nov 19, 2026Latest source record: Mar 31, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

100

Planned (sponsor's estimate)

Start

Mar 1, 2022

Primary completion

Apr 30, 2022

Study completion Jun 15, 2022

Sponsor

Lead sponsor
Olympic Ophthalmics, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Mar 31, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Other
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

A Usability Study of External Neuromodulation With iTEAR100 Generation 2. A study which evaluates user ability to train and access the iTEAR100 device in a telehealth environment.

Conditions

  • Dry Eye Syndromes

Interventions

  • iTEAR100Device

    Controlled Stimulation External Nasal Nerve to stimulate tear production

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. UsabilityTime frame: 30 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Olympic Ophthalmics

    Issaquah, Washington · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.